ODX - excellent position1 Jul 2020 12:07
Lots to like here. 1) Design Freeze now done for lateral flow test at point of care for Covid-19 antibodies, for government-backed consortium, this is de-risked, 2) PHE Validation, should be in July, and there are trials already under way, 3) scale up manufacturing, and this is funded from placing let alone other sources, 4) sales to follow, should be millions, and meantime 5) ongoing business with Mologic (inc ELISA test, so ODX have a menu of testing tools) 4 streams (1st: antibody; 2nd antigen), depending on demand. Plus ODX's other businesses. What's not to like. Once the PHE validation arrives, ODX's POC Covid-19 Antibody test will be a defacto part of the UK's revival strategy, and in demand globally I would expect too. IMHO, DYOR.